This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
protein
product name :
Human RPGRIP1L (aa 194-302) Control Fragment Recombinant Protein
catalog :
RP-105989
quantity :
100 uL
price :
US 259.00
product information
Product Type :
Protein
Product Name :
Human RPGRIP1L (aa 194-302) Control Fragment Recombinant Protein
Catalog # :
RP-105989
Quantity :
100 uL
Price :
US 259.00
Clonality :
Recombinant
Purity :
purified
Reactivity :
Human
Applications :
Blocking Assay: Assay-dependent, Control: Assay-dependent
Species :
Human
Storage :
-20 C, Avoid Freeze/Thaw Cycles
Description :
The protein encoded by this gene can localize to the basal body-centrosome complex or to primary cilia and centrosomes in ciliated cells. The encoded protein has been found to interact with nephrocystin-4. Defects in this gene are a cause of Joubert syndrome type 7 and Meckel syndrome type 5. Two transcript variants encoding different isoforms have been found for this gene.
Format :
Liquid
Applications w/Dilutions :
Blocking Assay: Assay-dependent, Control: Assay-dependent
Aliases :
1700047E16Rik; 4931437C01; CORS3; DKFZp686C0668; fantom; fantom homolog; Ftm; JBTS7; KIAA1005; MKS5; Nephrocystin-8; NPHP8; PPP1R134; Protein fantom; protein phosphatase 1, regulatory subunit 134; RGD1311099; RPGR-interacting protein 1-like protein; RPGRIP1 like; RPGRIP1L; Rpgrip1-like; RPGRIP1-like protein
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments